Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 7/20 | 0.36 |
| ▸ | DRD1 | P21728 | 7/20 | 0.36 |
| ▸ | DRD5 | P21918 | 7/20 | 0.36 |
| ▸ | DRD4 | P21917 | 2/20 | 0.36 |
| ▸ | DRD3 | P35462 | 4/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10471907 | 0.83 | DRD1 (0.44) | DRD2DRD1DRD5DRD4DRD3 | |
| SCHEMBL11215258 | 0.83 | DRD2 (0.42) | DRD2DRD1DRD5DRD4DRD3 | |
| SCHEMBL11168905 | 0.82 | PRNP (0.39) | DRD2DRD1DRD5DRD4DRD3 | |
| Bromide SCHEMBL11159318 | 0.82 | DRD1 (0.47) | DRD2DRD1DRD5DRD4DRD3 | |
| SCHEMBL11216598 | 0.81 | DRD2 (0.41) | DRD2DRD1DRD5DRD4DRD3 | |
| SCHEMBL11162257 | 0.81 | PTPN2 (0.38) | DRD2DRD1DRD5DRD4DRD3 | |
| SCHEMBL11162457 | 0.79 | DRD2 (0.41) | DRD2DRD1DRD5DRD4DRD3 | |
| SCHEMBL11216603 | 0.79 | DRD1 (0.43) | DRD2DRD1DRD5DRD4DRD3 | |
| SCHEMBL11155830 | 0.78 | KDM4E (0.38) | DRD2DRD1DRD5DRD4DRD3 | |
| SCHEMBL11167334 | 0.76 | ALDH1A1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0080012-A1 | 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate | SMITHKLINE BECKMAN CORPORATION (US) | 1983-06-01 | — | — | EP | disclosed |
| US-4265890-A | ANTIPSYCHOTIC, ANTIEMETICS | SMITHKLINE CORPORATION (US) | 1981-05-05 | — | — | US | disclosed |
| EP-0007070-A1 | 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity | SMITHKLINE BECKMAN CORPORATION (US) | 1980-01-23 | — | — | EP | disclosed |